Kinestica has been awarded by SME instrument grant to introduce Homer – a project aiming to develop affordable and widely accessible home rehabilitation system. By ranking among top 5 % of the EU SMEs applied, Kinestica`s great innovation potential has been recognized by the European commission. In Phase 1 of SME instrument a viability study will explore and analyze possibilities of successful market introduction.
“SME Instrument helps high-potential SMEs to develop groundbreaking innovative ideas for products, services or processes that are ready to face global market competition. The dedicated SME instrument's supports close-to-market activities, with the aim to give a strong boost to breakthrough innovation. Highly innovative SMEs with a clear commercial ambition and a potential for high growth and internationalization are the prime target,” according to the European commission website. Kinestica and Homer – Home rehabilitation system project was recognized as one of this innovative SMEs.
“Our mission is to help post-stroke and other neurological patients to overcome their everyday struggle with an affordable and widely accessible home rehabilitation system. Helping reduce disability is a very challenging, but rewarding task. We are looking forward to start working on this project. Project funds will primarily be used to define and outline research, development and marketing plan for Homer market launch,” says Aleš Hribar, Kinestica’s CEO.
Stroke is a devastating event which affects 15 million people around the world annually. According to the World Health Organization (WHO) stroke is the second single most common cause of death globally and in the EU region. While the number of stroke cases is growing, the mortality rate has drastically dropped, due to faster and more efficient treatment in the early acute stages. Combining this trend with a stagnating number of occupational and physical therapists we are facing a serious problem in access to rehabilitation. Consequently, more than 75 % of stroke survivors are left disabled and without proper care in the most crucial stages of recovery. Rehabilitation process lacks of duration, intensity, accessibility, affordability, objectivity, accessibility of patient data and therapists. These problems are alarming.
Homer will address all these issues by integrating motion capture technology with virtual reality and ICT platforms into one system. Patients will play games in virtual reality by moving affected the limb at the comfort of their home. Therapist will be able to monitor and adjust therapy via internet platform. Homer will fill the gap of intensive rehabilitation in the most crucial periods of recovery. It is an adjunct to conventional therapy which is not always available or provided to the desired level. Patients will benefit from intensive rehabilitation, leading to better outcomes in comparison with current methods in rehabilitation. Additional benefits include increased independence, reduced financial burden and better therapy decisions due to objective assessment provided for physicians and caregivers through open-source eHealth platform.
Kinestica team is positive that the project will impact and revolutionize post-stroke and neurological rehabilitation process and is looking forward to its development. Despite the excitement of bringing Homer to the market, the focus at this point is still on the clinical rehabilitation device – Bimeo Pro.
Bimeo PRO - rehabilitation device for upper extremities